Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for AC Immune (ACIU) over the last 3 years, with Q3 2019 value amounting to $19.8 million.

  • AC Immune's EPS (Basic) changed N/A to $19.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $19.8 million, marking a year-over-year change of. This contributed to the annual value of -$0.58 for FY2024, which is 1931.11% up from last year.
  • AC Immune's EPS (Basic) amounted to $19.8 million in Q3 2019.
  • AC Immune's 5-year EPS (Basic) high stood at $67.6 million for Q1 2019, and its period low was -$25.2 million during Q2 2019.
  • Its 3-year average for EPS (Basic) is $10.4 million, with a median of $23.1 in 2016.
  • Examining YoY changes over the last 5 years, AC Immune's EPS (Basic) showed a top increase of 2602.22% in 2016 and a maximum decrease of 2602.22% in 2016.
  • Quarter analysis of 3 years shows AC Immune's EPS (Basic) stood at -$0.13 in 2015, then grew by 26.02% to -$0.1 in 2016, then soared by 20804582623.12% to $19.8 million in 2019.
  • Its EPS (Basic) was $19.8 million in Q3 2019, compared to -$25.2 million in Q2 2019 and $67.6 million in Q1 2019.